Last reviewed · How we verify
Glargine & Glulisine
Glargine & Glulisine is a Small molecule drug developed by Cairo University. It is currently FDA-approved. Also known as: lantus, apidra.
At a glance
| Generic name | Glargine & Glulisine |
|---|---|
| Also known as | lantus, apidra |
| Sponsor | Cairo University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Evaluation of Insulin Glulisine (GP40321) Compared to Insulin Glulisine (Apidra® SoloStar®) in Type 1 Diabetes Mellitus Patients (PHASE3)
- Afrezza® INHALE-1 Study in Pediatrics (PHASE3)
- Degludec Glargine U300 Hospital Study (NA)
- Closed Loop From Onset in Type 1 Diabetes (NA)
- Dapagliflozin As Additional Treatment To Liraglutide And Insulin In Patients With Type 1 Diabetes (PHASE3)
- FLuctuATion Reduction With inSULin and Glp-1 Added togetheR (FLAT-SUGAR) (PHASE4)
- Comparison of Two Treatment Regimens in Patients With Type 2 Diabetes After Short-term Intensive Insulin Therapy (PHASE4)
- Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine in Patients With Type 2 Diabetes (LixiLan-India) (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Glargine & Glulisine CI brief — competitive landscape report
- Glargine & Glulisine updates RSS · CI watch RSS
- Cairo University portfolio CI
Frequently asked questions about Glargine & Glulisine
What is Glargine & Glulisine?
Glargine & Glulisine is a Small molecule drug developed by Cairo University.
Who makes Glargine & Glulisine?
Glargine & Glulisine is developed and marketed by Cairo University (see full Cairo University pipeline at /company/cairo-university).
Is Glargine & Glulisine also known as anything else?
Glargine & Glulisine is also known as lantus, apidra.
What development phase is Glargine & Glulisine in?
Glargine & Glulisine is FDA-approved (marketed).
Related
- Manufacturer: Cairo University — full pipeline
- Also known as: lantus, apidra
- Compare: Glargine & Glulisine vs similar drugs
- Pricing: Glargine & Glulisine cost, discount & access